Carlos Calderon-Ospina, MD, MSc, PhD, is an Associate Professor and Head of the Pharmacology Unit at the School of Medicine and Health Sciences, Universidad del Rosario (Colombia), a position he has held since 2007. He obtained his MD, MSc in Pharmacology, and PhD in Pharmaceutical Sciences from the National University of Colombia, and completed a postdoctoral research stay at Ludwig-Maximilians-Universität München (Germany). He has also served as a Visiting Professor of Pharmacology at Inönü University (Türkiye). His research focuses on pharmacovigilance, pharmacoepidemiology, pharmacogenetics, and clinical pharmacology, with a translational perspective bridging molecular mechanisms and real-world evidence. He has extensive experience in systematic reviews and meta-analyses aligned with Cochrane standards. He has worked in pharmacovigilance and Good Clinical Practice at the Colombian drug regulatory authority and as a consultant to the pharmaceutical industry. He has authored more than 75 peer-reviewed publications and serves on the Editorial Board of BMJ Case Reports, and has acted as Guest Editor for Therapeutic Advances in Drug Safety. He has been a member of the British Pharmacological Society, ISoP, ISPE, and IASP. He was recognized as a top peer reviewer by Pharmacoepidemiology and Drug Safety (2012) and appointed Distinguished Professor at Universidad del Rosario. Since 2022, he has been recognized as a Senior Researcher by the Colombian Ministry of Science.